EXEL EBITDA | Exelixis Inc

Exelixis Inc (EXEL) EBITDA

2026-07-03: Basis Reported; EBITDA $255.40M*; Operating income $248.41M; Depreciation and amortization $6.98M*.
2026-04-03: Basis Reported; EBITDA $258.29M; Operating income (m); Depreciation and amortization (m).
2026-01-02: Basis Reported; EBITDA $242.16M; Operating income (m); Depreciation and amortization (m).
2025-10-03: Basis Reported; EBITDA $243.96M*; Operating income $236.54M; Depreciation and amortization $7.42M*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-04-03
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-07-03	Reported	$255.40M*	$248.41M	$6.98M*	$628.69M	40.62%*	$6.82M*	$307.74M*	$20.66M	$211.99M	$147.63M	$50.63M
2026-04-03	Reported	$258.29M	(m)	(m)	(m)	42.29%	$1.51M	$251.84M	$19.95M	$199.92M	$139.60M	$57.22M
2026-01-02	Reported	$242.16M	(m)	(m)	(m)	40.45%	(m)	(m)	(m)	(m)	(m)	(m)
2025-10-03	Reported	$243.96M*	$236.54M	$7.42M*	$597.75M	40.81%*	$1.48M*	$290.32M*	$18.57M	$199.16M	$123.66M	$58.84M
2025-07-04	Reported	$220.92M*	$213.58M	$7.34M*	$568.26M	38.88%*	$2.84M*	$48.99M*	$19.47M	$200.36M	$134.86M	$45.57M
2025-04-04	Reported	$194.2M	(m)	(m)	(m)	34.96%	$2.95M	$211.44M	$19.17M	$212.23M	$137.18M	$46.07M
2025-01-03	Reported	$170.85M	(m)	(m)	(m)	30.14%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-27	Reported	$143.53M*	$136.07M	$7.45M*	$539.54M	26.60%*	$8.20M*	$271.34M*	$17.33M	$222.57M	$111.80M	$36.78M
2024-06-28	Reported	$283.20M*	$275.87M	$7.33M*	$637.18M	44.45%*	$6.57M*	$119.55M*	$17.67M	$211.15M	$132.01M	$66.73M
2024-03-29	Reported	$35.84M	(m)	(m)	(m)	8.43%	$9.69M	$68.82M	$21.26M	$227.69M	$113.98M	$11.95M
2023-12-29	Reported	$88.31M	(m)	(m)	(m)	18.41%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-29	Reported	-$11.29M*	-$17.58M	$6.30M*	$471.92M	-2.39%*	$9.37M*	$117.37M*	$18.77M	$332.58M	$138.14M	$4.78M
2023-06-30	Reported	$83.89M*	$77.85M	$6.04M*	$469.85M	17.85%*	$5.94M*	$120.98M*	$17.70M	$232.57M	$141.72M	$19.21M
2023-03-31	Reported	$35.69M	(m)	(m)	(m)	8.73%	$12.02M	$84.41M	$14.31M	$234.25M	$131.40M	$8.25M
2022-12-30	Reported	-$42.13M	(m)	(m)	(m)	-9.94%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$88.28M*	$82.61M	$5.66M*	$411.74M	21.44%*	$5.04M*	$110.07M*	$15.30M	$198.84M	$114.98M	$18.83M
2022-07-01	Reported	$88.48M*	$83.71M	$4.78M*	$419.43M	21.10%*	$7.34M*	$31.13M*	$13.48M	$199.48M	$122.76M	$17.84M
2022-04-01	Reported	$87.73M	(m)	(m)	(m)	24.65%	$5.61M	$147.72M	$13.20M	$156.67M	$102.86M	$16.66M
2021-12-31	Reported	$118.58M	(m)	(m)	(m)	26.28%	(m)	(m)	(m)	(m)	(m)	(m)
2021-10-01	Reported	$56.42M*	$51.62M	$4.80M*	$328.42M	17.18%*	$14.50M*	$83.31M*	$11.87M	$163.37M	$101.56M	$15.06M
2021-07-02	Reported	$126.68M*	$123.01M	$3.67M*	$385.18M	32.89%*	$20.21M*	$181.50M*	$14.88M	$148.79M	$98.50M	$28.80M
2021-04-02	Reported	-$1.38M	(m)	(m)	(m)	-0.51%	$13.56M	$39.54M	$13.20M	$159.29M	$102.35M	-$3.62M
2021-01-01	Reported	$26.71M	(m)	(m)	(m)	9.89%	(m)	(m)	(m)	(m)	(m)	(m)
2020-10-02	Reported	-$40.23M*	-$42.58M	$2.35M*	$231.09M	-17.41%*	$6.13M*	$17.94M*	$8.72M	$176.76M	$88.19M	-$5.98M
2020-07-03	Reported	$77.73M*	$75.53M	$2.20M*	$259.48M	29.96%*	$6.96M*	$101.68M*	$9.22M	$114.93M	$59.79M	$13.88M
2020-04-03	Reported	$54.98M	(m)	(m)	(m)	24.23%	$2.96M	$56.07M	$9.29M	$101.88M	$62.94M	$11.42M
2020-01-03	Reported	$79.58M	(m)	(m)	(m)	33.11%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-27	Reported	$117.70M*	$115.61M	$2.09M*	$271.70M	43.32%*	$2.06M*	$75.61M*	$7.54M	$97.30M	$51.27M	$25.20M
2019-06-28	Reported	$94.03M*	$91.99M	$2.04M*	$240.28M	39.13%*	$1.21M*	$131.73M*	$7.54M	$81.93M	$58.81M	$20.73M
2019-03-29	Reported	$86.52M	(m)	(m)	(m)	40.15%	$2.31M	$161.59M	$7.50M	$63.29M	$60.14M	$14.90M
2018-12-28	Reported	$113.64M	(m)	(m)	(m)	49.71%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-29	Reported	(m)	$125.18M	(m)	$225.40M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-28	Reported	$126.88M*	$125.18M	$1.70M*	$225.40M	56.29%*	$15.22M*	$164.86M*	$7.36M	$44.74M	$48.12M	$2.32M
2018-06-29	Reported	$86.58M*	$85.77M	$805.00K*	$186.11M	46.52%*	$12.23M*	$74.47M*	$6.00M	$42.49M	$51.85M	$901.00K
2018-06-29	Reported	(m)	$85.77M	(m)	$186.11M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Reported	(m)	$116.31M	(m)	$213.72M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-30	Reported	$116.68M	(m)	(m)	(m)	54.59%	$2.95M	$71.81M	$5.64M	$37.76M	$54.02M	$2.51M
2017-12-29	Reported	$37.78M	(m)	(m)	(m)	31.46%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$81.46M*	$81.18M	$279.00K*	$152.51M	53.41%*	$1.14M*	$37.87M*	(m)	$28.54M	$38.13M	$3.21M
2017-09-29	Reported	$81.46M*	$81.18M	$279.00K*	$152.51M	53.41%*	$1.15M*	$37.87M*	$4.66M	$28.54M	$38.13M	$3.21M
2017-06-30	Reported	(m)	$27.11M	(m)	$99.01M	(m)	(m)	(m)	(m)	$28.21M	$40.67M	$581.00K
2017-03-31	Reported	$20.47M	(m)	(m)	(m)	25.30%	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	$39.13M	(m)	(m)	(m)	50.44%	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-30	Reported	(m)	$38.88M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$7.56M*	$7.26M	$298.00K*	(m)	(m)	$33.00K*	-$5.78M*	(m)	$20.26M	$32.46M	$0.00
2016-09-30	Reported	(m)	$7.26M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-07-01	Reported	(m)	-$25.14M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Reported	-$24.91M*	-$25.14M	$227.00K*	(m)	(m)	$401.00K*	-$25.73M*	(m)	$22.98M	$35.82M	$0.00
2016-04-01	Reported	(m)	-$49.13M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Reported	-$48.91M	(m)	(m)	(m)	-317.02%	$682.00K	$156.81M	(m)	$28.93M	$34.86M	$0.00
2015-12-31	Reported	-$31.26M	(m)	(m)	(m)	-314.52%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$35.40M*	-$35.78M	$379.00K*	(m)	(m)	$20.00K*	-$34.23M*	(m)	$26.09M	$17.84M	(m)
2015-06-30	Reported	-$30.89M*	-$31.28M	$387.00K*	(m)	(m)	$63.00K*	-$26.83M*	(m)	$24.51M	$12.79M	(m)
2015-03-31	Reported	-$22.46M	(m)	(m)	(m)	-239.27%	$31.00K	-$45.09M	(m)	$22.28M	$9.53M	(m)
2014-12-31	Reported	-$46.83M	(m)	(m)	(m)	-636.90%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$49.65M*	-$51.57M	$1.92M*	(m)	(m)	$108.00K*	-$58.01M*	(m)	$43.63M	$9.91M	(m)
2014-06-30	Reported	-$61.09M*	-$61.69M	$595.00K*	(m)	(m)	-$40.00K*	-$55.34M*	(m)	$50.98M	$16.47M	(m)
2014-03-31	Reported	-$64.49M	(m)	(m)	(m)	-1314.78%	$384.00K	-$72.09M	(m)	$54.85M	$14.69M	(m)
2013-12-31	Reported	-$58.75M	(m)	(m)	(m)	-1351.48%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$55.16M*	-$55.91M	$754.00K*	(m)	(m)	$677.00K*	-$56.99M*	(m)	$47.35M	$13.60M	$0.00
2013-06-30	Reported	-$50.51M*	-$51.30M	$786.00K*	(m)	(m)	$673.00K*	-$40.03M*	(m)	$49.08M	$13.18M	$0.00
2013-03-31	Reported	-$33.17M	(m)	(m)	(m)	-343.03%	$729.00K	-$54.41M	(m)	$32.73M	$10.54M	$0.00
2012-12-31	Reported	-$40.53M	(m)	(m)	(m)	-518.71%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$24.01M*	-$25.44M	$1.43M*	(m)	(m)	$1.02M*	-$34.05M*	(m)	$30.68M	$7.34M	$10.00K
2012-06-30	Reported	-$31.32M*	-$32.72M	$1.41M*	(m)	(m)	$437.00K*	-$35.39M*	(m)	$32.61M	(m)	$12.00K
2012-03-31	Reported	-$21.06M	(m)	(m)	(m)	-113.79%	$72.00K	-$14.97M	(m)	$33.10M	(m)	$11.00K
2011-12-31	Reported	$53.36M	(m)	(m)	(m)	57.19%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	$80.81M*	$79.70M	$1.11M*	(m)	(m)	$144.00K*	-$43.27M*	(m)	$37.47M	(m)	$0.00
2011-06-30	Reported	-$16.01M*	-$18.01M	$2.00M*	(m)	(m)	$163.00K*	-$43.52M*	(m)	$42.90M	(m)	$0.00
2011-03-31	Reported	-$21.8M	(m)	(m)	(m)	-60.74%	$405.00K	-$43.28M	(m)	$45.69M	(m)	(m)
2010-12-31	Reported	-$11.84M	(m)	(m)	(m)	-29.04%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$1.80M*	-$4.21M	$2.40M*	(m)	(m)	$650.00K*	-$43.83M*	(m)	$49.39M	(m)	-$72.00K
2010-06-30	Reported	(m)	-$25.63M	(m)	(m)	(m)	(m)	(m)	(m)	$54.24M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-01-02	Reported	$901.25M	(m)	(m)	(m)	38.84%	$8.43M	$884.27M	$83.70M	$825.00M	$518.73M	$158.64M
2025-01-03	Reported	$633.42M	(m)	(m)	(m)	29.21%	$28.43M	$699.97M	$76.22M	$910.41M	$492.13M	$160.37M
2023-12-29	Reported	$196.6M	(m)	(m)	(m)	10.74%	$40.47M	$333.32M	$72.55M	$1.04B	$542.71M	$49.76M
2022-12-30	Reported	$222.36M	(m)	(m)	(m)	13.80%	$27.71M	$362.61M	$57.91M	$891.81M	$459.86M	$52.07M
2021-12-31	Reported	$300.3M	(m)	(m)	(m)	20.93%	$54.23M	$400.80M	$52.87M	$693.72M	$401.71M	$63.09M
2021-10-01	Rolling	(m)	$194.32M*	(m)	$1.25B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-07-02	Rolling	(m)	$100.12M*	(m)	$1.16B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-04-02	Rolling	(m)	$52.64M*	(m)	$1.03B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-01-01	Reported	$119.2M	(m)	(m)	(m)	12.07%	$30.34M	$208.98M	$36.27M	$547.85M	$293.36M	$19.06M
2021-01-01	Rolling	(m)	$110.06M*	(m)	$987.54M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-10-02	Rolling	(m)	$163.08M*	(m)	$957.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-07-03	Rolling	(m)	$321.26M*	(m)	$998.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-04-03	Rolling	(m)	$337.72M*	(m)	$979.20M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-01-03	Reported	$377.82M	(m)	(m)	(m)	39.04%	$12.83M	$526.96M	$33.10M	$336.96M	$228.24M	$77.10M
2020-01-03	Rolling	(m)	$369.47M*	(m)	$967.77M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-28	Reported	$443.77M	(m)	(m)	(m)	51.97%	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-29	Reported	$167.1M	(m)	(m)	(m)	36.93%	$21.14M	$165.61M	$15.07M	$112.17M	$159.33M	$4.35M
2016-12-31	Reported	-$27.12M	(m)	(m)	(m)	-14.17%	$1.70M	$206.30M	(m)	$95.97M	$116.14M	$0.00
2016-12-30	Reported	-$27.12M	(m)	(m)	(m)	-14.17%	$1.70M	$210.40M	$6.55M	$95.97M	$116.14M	$0.00
2016-06-30	Rolling	(m)	-$141.65M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$147.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-01-01	Reported	-$120.02M	(m)	(m)	(m)	-322.86%	$447.00K	-$141.05M	(m)	$96.35M	$57.30M	$55.00K
2015-12-31	Reported	-$120.02M	(m)	(m)	(m)	-322.86%	$447.00K	-$141.59M	(m)	$96.35M	$57.30M	$55.00K
2015-12-31	Rolling	(m)	-$121.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$136.03M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$151.82M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$182.23M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$222.07M	(m)	(m)	(m)	-884.34%	$474.00K	-$235.41M	(m)	$189.10M	$50.83M	-$182.00K
2014-12-31	Rolling	(m)	-$224.46M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$197.59M	(m)	(m)	(m)	-630.50%	$2.17M	-$198.77M	(m)	$178.76M	$50.96M	-$96.00K
2012-12-31	Reported	-$116.92M	(m)	(m)	(m)	-246.41%	$2.72M	-$123.15M	(m)	$128.88M	$31.84M	$107.00K
2011-12-31	Reported	$96.36M	(m)	(m)	(m)	33.27%	$991.00K	-$159.23M	(m)	$156.84M	$33.13M	$1.29M
2010-12-31	Reported	-$80.85M	(m)	(m)	(m)	-43.69%	$1.81M	-$101.05M	(m)	$210.68M	(m)	-$72.00K
2009-12-31	Reported	-$109.31M	(m)	(m)	(m)	-72.03%	$5.91M	-$14.59M	(m)	$234.70M	(m)	-$1.29M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78